FDA Issues Guidance On Proving Generic-Drug Stability
The Food and Drug Administration on Tuesday answered a long-standing question from generic-drug sponsors, saying that generics makers should follow the same standards as new drug applicants when proving the stability...To view the full article, register now.
Already a subscriber? Click here to view full article